Global Pharmacogenomics Services Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Pharmacogenomics Services market size was valued at US$ million in 2023. With growing demand in downstream market, the Pharmacogenomics Services is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Pharmacogenomics Services market. Pharmacogenomics Services are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Pharmacogenomics Services. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Pharmacogenomics Services market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Pharmacogenomics Services market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Pharmacogenomics Services market. It may include historical data, market segmentation by Type (e.g., Genotyping, SNP Identification), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Pharmacogenomics Services market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Pharmacogenomics Services market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Pharmacogenomics Services industry. This include advancements in Pharmacogenomics Services technology, Pharmacogenomics Services new entrants, Pharmacogenomics Services new investment, and other innovations that are shaping the future of Pharmacogenomics Services.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Pharmacogenomics Services market. It includes factors influencing customer ' purchasing decisions, preferences for Pharmacogenomics Services product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Pharmacogenomics Services market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Pharmacogenomics Services market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Pharmacogenomics Services market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Pharmacogenomics Services industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Pharmacogenomics Services market.
Market Segmentation:
Pharmacogenomics Services market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Pharmacogenomics Services market size was valued at US$ million in 2023. With growing demand in downstream market, the Pharmacogenomics Services is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Pharmacogenomics Services market. Pharmacogenomics Services are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Pharmacogenomics Services. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Pharmacogenomics Services market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Pharmacogenomics Services market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Pharmacogenomics Services market. It may include historical data, market segmentation by Type (e.g., Genotyping, SNP Identification), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Pharmacogenomics Services market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Pharmacogenomics Services market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Pharmacogenomics Services industry. This include advancements in Pharmacogenomics Services technology, Pharmacogenomics Services new entrants, Pharmacogenomics Services new investment, and other innovations that are shaping the future of Pharmacogenomics Services.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Pharmacogenomics Services market. It includes factors influencing customer ' purchasing decisions, preferences for Pharmacogenomics Services product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Pharmacogenomics Services market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Pharmacogenomics Services market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Pharmacogenomics Services market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Pharmacogenomics Services industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Pharmacogenomics Services market.
Market Segmentation:
Pharmacogenomics Services market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Genotyping
- SNP Identification
- Pharmacogenetic Testing
- Others
- Oncology
- Infectious Diseases
- Psychiatry
- Cardiovascular
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Abbott Laboratories
- Admera Health, LLC
- Mesa Laboratories, Inc.
- Dynamic DNA Laboratories
- F. Hoffmann-La Roche Ltd.
- GeneOmbio Technologies Pvt Ltd.
- Exact Sciences Corporation
- Illumina, Inc.
- Laboratory Corporation of America Holdings
- Myriad Genetics, Inc.
- OmeCare
- QIAGEN N.V.
- Quest Diagnostics Incorporated
- Thermo Fisher Scientific Inc.
- Precipio
- 23andMe, Inc.
- OneOme, LLC
- DiaCarta, Inc.
- OPKO Health
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pharmacogenomics Services Market Size 2019-2030
2.1.2 Pharmacogenomics Services Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Pharmacogenomics Services Segment by Type
2.2.1 Genotyping
2.2.2 SNP Identification
2.2.3 Pharmacogenetic Testing
2.2.4 Others
2.3 Pharmacogenomics Services Market Size by Type
2.3.1 Pharmacogenomics Services Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Pharmacogenomics Services Market Size Market Share by Type (2019-2024)
2.4 Pharmacogenomics Services Segment by Application
2.4.1 Oncology
2.4.2 Infectious Diseases
2.4.3 Psychiatry
2.4.4 Cardiovascular
2.4.5 Others
2.5 Pharmacogenomics Services Market Size by Application
2.5.1 Pharmacogenomics Services Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Pharmacogenomics Services Market Size Market Share by Application (2019-2024)
3 PHARMACOGENOMICS SERVICES MARKET SIZE BY PLAYER
3.1 Pharmacogenomics Services Market Size Market Share by Players
3.1.1 Global Pharmacogenomics Services Revenue by Players (2019-2024)
3.1.2 Global Pharmacogenomics Services Revenue Market Share by Players (2019-2024)
3.2 Global Pharmacogenomics Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PHARMACOGENOMICS SERVICES BY REGIONS
4.1 Pharmacogenomics Services Market Size by Regions (2019-2024)
4.2 Americas Pharmacogenomics Services Market Size Growth (2019-2024)
4.3 APAC Pharmacogenomics Services Market Size Growth (2019-2024)
4.4 Europe Pharmacogenomics Services Market Size Growth (2019-2024)
4.5 Middle East & Africa Pharmacogenomics Services Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Pharmacogenomics Services Market Size by Country (2019-2024)
5.2 Americas Pharmacogenomics Services Market Size by Type (2019-2024)
5.3 Americas Pharmacogenomics Services Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmacogenomics Services Market Size by Region (2019-2024)
6.2 APAC Pharmacogenomics Services Market Size by Type (2019-2024)
6.3 APAC Pharmacogenomics Services Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Pharmacogenomics Services by Country (2019-2024)
7.2 Europe Pharmacogenomics Services Market Size by Type (2019-2024)
7.3 Europe Pharmacogenomics Services Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pharmacogenomics Services by Region (2019-2024)
8.2 Middle East & Africa Pharmacogenomics Services Market Size by Type (2019-2024)
8.3 Middle East & Africa Pharmacogenomics Services Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PHARMACOGENOMICS SERVICES MARKET FORECAST
10.1 Global Pharmacogenomics Services Forecast by Regions (2025-2030)
10.1.1 Global Pharmacogenomics Services Forecast by Regions (2025-2030)
10.1.2 Americas Pharmacogenomics Services Forecast
10.1.3 APAC Pharmacogenomics Services Forecast
10.1.4 Europe Pharmacogenomics Services Forecast
10.1.5 Middle East & Africa Pharmacogenomics Services Forecast
10.2 Americas Pharmacogenomics Services Forecast by Country (2025-2030)
10.2.1 United States Pharmacogenomics Services Market Forecast
10.2.2 Canada Pharmacogenomics Services Market Forecast
10.2.3 Mexico Pharmacogenomics Services Market Forecast
10.2.4 Brazil Pharmacogenomics Services Market Forecast
10.3 APAC Pharmacogenomics Services Forecast by Region (2025-2030)
10.3.1 China Pharmacogenomics Services Market Forecast
10.3.2 Japan Pharmacogenomics Services Market Forecast
10.3.3 Korea Pharmacogenomics Services Market Forecast
10.3.4 Southeast Asia Pharmacogenomics Services Market Forecast
10.3.5 India Pharmacogenomics Services Market Forecast
10.3.6 Australia Pharmacogenomics Services Market Forecast
10.4 Europe Pharmacogenomics Services Forecast by Country (2025-2030)
10.4.1 Germany Pharmacogenomics Services Market Forecast
10.4.2 France Pharmacogenomics Services Market Forecast
10.4.3 UK Pharmacogenomics Services Market Forecast
10.4.4 Italy Pharmacogenomics Services Market Forecast
10.4.5 Russia Pharmacogenomics Services Market Forecast
10.5 Middle East & Africa Pharmacogenomics Services Forecast by Region (2025-2030)
10.5.1 Egypt Pharmacogenomics Services Market Forecast
10.5.2 South Africa Pharmacogenomics Services Market Forecast
10.5.3 Israel Pharmacogenomics Services Market Forecast
10.5.4 Turkey Pharmacogenomics Services Market Forecast
10.5.5 GCC Countries Pharmacogenomics Services Market Forecast
10.6 Global Pharmacogenomics Services Forecast by Type (2025-2030)
10.7 Global Pharmacogenomics Services Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Pharmacogenomics Services Product Offered
11.1.3 Abbott Laboratories Pharmacogenomics Services Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 Admera Health, LLC
11.2.1 Admera Health, LLC Company Information
11.2.2 Admera Health, LLC Pharmacogenomics Services Product Offered
11.2.3 Admera Health, LLC Pharmacogenomics Services Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Admera Health, LLC Main Business Overview
11.2.5 Admera Health, LLC Latest Developments
11.3 Mesa Laboratories, Inc.
11.3.1 Mesa Laboratories, Inc. Company Information
11.3.2 Mesa Laboratories, Inc. Pharmacogenomics Services Product Offered
11.3.3 Mesa Laboratories, Inc. Pharmacogenomics Services Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Mesa Laboratories, Inc. Main Business Overview
11.3.5 Mesa Laboratories, Inc. Latest Developments
11.4 Dynamic DNA Laboratories
11.4.1 Dynamic DNA Laboratories Company Information
11.4.2 Dynamic DNA Laboratories Pharmacogenomics Services Product Offered
11.4.3 Dynamic DNA Laboratories Pharmacogenomics Services Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Dynamic DNA Laboratories Main Business Overview
11.4.5 Dynamic DNA Laboratories Latest Developments
11.5 F. Hoffmann-La Roche Ltd.
11.5.1 F. Hoffmann-La Roche Ltd. Company Information
11.5.2 F. Hoffmann-La Roche Ltd. Pharmacogenomics Services Product Offered
11.5.3 F. Hoffmann-La Roche Ltd. Pharmacogenomics Services Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 F. Hoffmann-La Roche Ltd. Main Business Overview
11.5.5 F. Hoffmann-La Roche Ltd. Latest Developments
11.6 GeneOmbio Technologies Pvt Ltd.
11.6.1 GeneOmbio Technologies Pvt Ltd. Company Information
11.6.2 GeneOmbio Technologies Pvt Ltd. Pharmacogenomics Services Product Offered
11.6.3 GeneOmbio Technologies Pvt Ltd. Pharmacogenomics Services Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 GeneOmbio Technologies Pvt Ltd. Main Business Overview
11.6.5 GeneOmbio Technologies Pvt Ltd. Latest Developments
11.7 Exact Sciences Corporation
11.7.1 Exact Sciences Corporation Company Information
11.7.2 Exact Sciences Corporation Pharmacogenomics Services Product Offered
11.7.3 Exact Sciences Corporation Pharmacogenomics Services Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Exact Sciences Corporation Main Business Overview
11.7.5 Exact Sciences Corporation Latest Developments
11.8 Illumina, Inc.
11.8.1 Illumina, Inc. Company Information
11.8.2 Illumina, Inc. Pharmacogenomics Services Product Offered
11.8.3 Illumina, Inc. Pharmacogenomics Services Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Illumina, Inc. Main Business Overview
11.8.5 Illumina, Inc. Latest Developments
11.9 Laboratory Corporation of America Holdings
11.9.1 Laboratory Corporation of America Holdings Company Information
11.9.2 Laboratory Corporation of America Holdings Pharmacogenomics Services Product Offered
11.9.3 Laboratory Corporation of America Holdings Pharmacogenomics Services Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Laboratory Corporation of America Holdings Main Business Overview
11.9.5 Laboratory Corporation of America Holdings Latest Developments
11.10 Myriad Genetics, Inc.
11.10.1 Myriad Genetics, Inc. Company Information
11.10.2 Myriad Genetics, Inc. Pharmacogenomics Services Product Offered
11.10.3 Myriad Genetics, Inc. Pharmacogenomics Services Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Myriad Genetics, Inc. Main Business Overview
11.10.5 Myriad Genetics, Inc. Latest Developments
11.11 OmeCare
11.11.1 OmeCare Company Information
11.11.2 OmeCare Pharmacogenomics Services Product Offered
11.11.3 OmeCare Pharmacogenomics Services Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 OmeCare Main Business Overview
11.11.5 OmeCare Latest Developments
11.12 QIAGEN N.V.
11.12.1 QIAGEN N.V. Company Information
11.12.2 QIAGEN N.V. Pharmacogenomics Services Product Offered
11.12.3 QIAGEN N.V. Pharmacogenomics Services Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 QIAGEN N.V. Main Business Overview
11.12.5 QIAGEN N.V. Latest Developments
11.13 Quest Diagnostics Incorporated
11.13.1 Quest Diagnostics Incorporated Company Information
11.13.2 Quest Diagnostics Incorporated Pharmacogenomics Services Product Offered
11.13.3 Quest Diagnostics Incorporated Pharmacogenomics Services Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Quest Diagnostics Incorporated Main Business Overview
11.13.5 Quest Diagnostics Incorporated Latest Developments
11.14 Thermo Fisher Scientific Inc.
11.14.1 Thermo Fisher Scientific Inc. Company Information
11.14.2 Thermo Fisher Scientific Inc. Pharmacogenomics Services Product Offered
11.14.3 Thermo Fisher Scientific Inc. Pharmacogenomics Services Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Thermo Fisher Scientific Inc. Main Business Overview
11.14.5 Thermo Fisher Scientific Inc. Latest Developments
11.15 Precipio
11.15.1 Precipio Company Information
11.15.2 Precipio Pharmacogenomics Services Product Offered
11.15.3 Precipio Pharmacogenomics Services Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Precipio Main Business Overview
11.15.5 Precipio Latest Developments
11.16 23andMe, Inc.
11.16.1 23andMe, Inc. Company Information
11.16.2 23andMe, Inc. Pharmacogenomics Services Product Offered
11.16.3 23andMe, Inc. Pharmacogenomics Services Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 23andMe, Inc. Main Business Overview
11.16.5 23andMe, Inc. Latest Developments
11.17 OneOme, LLC
11.17.1 OneOme, LLC Company Information
11.17.2 OneOme, LLC Pharmacogenomics Services Product Offered
11.17.3 OneOme, LLC Pharmacogenomics Services Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 OneOme, LLC Main Business Overview
11.17.5 OneOme, LLC Latest Developments
11.18 DiaCarta, Inc.
11.18.1 DiaCarta, Inc. Company Information
11.18.2 DiaCarta, Inc. Pharmacogenomics Services Product Offered
11.18.3 DiaCarta, Inc. Pharmacogenomics Services Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 DiaCarta, Inc. Main Business Overview
11.18.5 DiaCarta, Inc. Latest Developments
11.19 OPKO Health
11.19.1 OPKO Health Company Information
11.19.2 OPKO Health Pharmacogenomics Services Product Offered
11.19.3 OPKO Health Pharmacogenomics Services Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 OPKO Health Main Business Overview
11.19.5 OPKO Health Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pharmacogenomics Services Market Size 2019-2030
2.1.2 Pharmacogenomics Services Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Pharmacogenomics Services Segment by Type
2.2.1 Genotyping
2.2.2 SNP Identification
2.2.3 Pharmacogenetic Testing
2.2.4 Others
2.3 Pharmacogenomics Services Market Size by Type
2.3.1 Pharmacogenomics Services Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Pharmacogenomics Services Market Size Market Share by Type (2019-2024)
2.4 Pharmacogenomics Services Segment by Application
2.4.1 Oncology
2.4.2 Infectious Diseases
2.4.3 Psychiatry
2.4.4 Cardiovascular
2.4.5 Others
2.5 Pharmacogenomics Services Market Size by Application
2.5.1 Pharmacogenomics Services Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Pharmacogenomics Services Market Size Market Share by Application (2019-2024)
3 PHARMACOGENOMICS SERVICES MARKET SIZE BY PLAYER
3.1 Pharmacogenomics Services Market Size Market Share by Players
3.1.1 Global Pharmacogenomics Services Revenue by Players (2019-2024)
3.1.2 Global Pharmacogenomics Services Revenue Market Share by Players (2019-2024)
3.2 Global Pharmacogenomics Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PHARMACOGENOMICS SERVICES BY REGIONS
4.1 Pharmacogenomics Services Market Size by Regions (2019-2024)
4.2 Americas Pharmacogenomics Services Market Size Growth (2019-2024)
4.3 APAC Pharmacogenomics Services Market Size Growth (2019-2024)
4.4 Europe Pharmacogenomics Services Market Size Growth (2019-2024)
4.5 Middle East & Africa Pharmacogenomics Services Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Pharmacogenomics Services Market Size by Country (2019-2024)
5.2 Americas Pharmacogenomics Services Market Size by Type (2019-2024)
5.3 Americas Pharmacogenomics Services Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmacogenomics Services Market Size by Region (2019-2024)
6.2 APAC Pharmacogenomics Services Market Size by Type (2019-2024)
6.3 APAC Pharmacogenomics Services Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Pharmacogenomics Services by Country (2019-2024)
7.2 Europe Pharmacogenomics Services Market Size by Type (2019-2024)
7.3 Europe Pharmacogenomics Services Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pharmacogenomics Services by Region (2019-2024)
8.2 Middle East & Africa Pharmacogenomics Services Market Size by Type (2019-2024)
8.3 Middle East & Africa Pharmacogenomics Services Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PHARMACOGENOMICS SERVICES MARKET FORECAST
10.1 Global Pharmacogenomics Services Forecast by Regions (2025-2030)
10.1.1 Global Pharmacogenomics Services Forecast by Regions (2025-2030)
10.1.2 Americas Pharmacogenomics Services Forecast
10.1.3 APAC Pharmacogenomics Services Forecast
10.1.4 Europe Pharmacogenomics Services Forecast
10.1.5 Middle East & Africa Pharmacogenomics Services Forecast
10.2 Americas Pharmacogenomics Services Forecast by Country (2025-2030)
10.2.1 United States Pharmacogenomics Services Market Forecast
10.2.2 Canada Pharmacogenomics Services Market Forecast
10.2.3 Mexico Pharmacogenomics Services Market Forecast
10.2.4 Brazil Pharmacogenomics Services Market Forecast
10.3 APAC Pharmacogenomics Services Forecast by Region (2025-2030)
10.3.1 China Pharmacogenomics Services Market Forecast
10.3.2 Japan Pharmacogenomics Services Market Forecast
10.3.3 Korea Pharmacogenomics Services Market Forecast
10.3.4 Southeast Asia Pharmacogenomics Services Market Forecast
10.3.5 India Pharmacogenomics Services Market Forecast
10.3.6 Australia Pharmacogenomics Services Market Forecast
10.4 Europe Pharmacogenomics Services Forecast by Country (2025-2030)
10.4.1 Germany Pharmacogenomics Services Market Forecast
10.4.2 France Pharmacogenomics Services Market Forecast
10.4.3 UK Pharmacogenomics Services Market Forecast
10.4.4 Italy Pharmacogenomics Services Market Forecast
10.4.5 Russia Pharmacogenomics Services Market Forecast
10.5 Middle East & Africa Pharmacogenomics Services Forecast by Region (2025-2030)
10.5.1 Egypt Pharmacogenomics Services Market Forecast
10.5.2 South Africa Pharmacogenomics Services Market Forecast
10.5.3 Israel Pharmacogenomics Services Market Forecast
10.5.4 Turkey Pharmacogenomics Services Market Forecast
10.5.5 GCC Countries Pharmacogenomics Services Market Forecast
10.6 Global Pharmacogenomics Services Forecast by Type (2025-2030)
10.7 Global Pharmacogenomics Services Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Pharmacogenomics Services Product Offered
11.1.3 Abbott Laboratories Pharmacogenomics Services Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 Admera Health, LLC
11.2.1 Admera Health, LLC Company Information
11.2.2 Admera Health, LLC Pharmacogenomics Services Product Offered
11.2.3 Admera Health, LLC Pharmacogenomics Services Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Admera Health, LLC Main Business Overview
11.2.5 Admera Health, LLC Latest Developments
11.3 Mesa Laboratories, Inc.
11.3.1 Mesa Laboratories, Inc. Company Information
11.3.2 Mesa Laboratories, Inc. Pharmacogenomics Services Product Offered
11.3.3 Mesa Laboratories, Inc. Pharmacogenomics Services Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Mesa Laboratories, Inc. Main Business Overview
11.3.5 Mesa Laboratories, Inc. Latest Developments
11.4 Dynamic DNA Laboratories
11.4.1 Dynamic DNA Laboratories Company Information
11.4.2 Dynamic DNA Laboratories Pharmacogenomics Services Product Offered
11.4.3 Dynamic DNA Laboratories Pharmacogenomics Services Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Dynamic DNA Laboratories Main Business Overview
11.4.5 Dynamic DNA Laboratories Latest Developments
11.5 F. Hoffmann-La Roche Ltd.
11.5.1 F. Hoffmann-La Roche Ltd. Company Information
11.5.2 F. Hoffmann-La Roche Ltd. Pharmacogenomics Services Product Offered
11.5.3 F. Hoffmann-La Roche Ltd. Pharmacogenomics Services Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 F. Hoffmann-La Roche Ltd. Main Business Overview
11.5.5 F. Hoffmann-La Roche Ltd. Latest Developments
11.6 GeneOmbio Technologies Pvt Ltd.
11.6.1 GeneOmbio Technologies Pvt Ltd. Company Information
11.6.2 GeneOmbio Technologies Pvt Ltd. Pharmacogenomics Services Product Offered
11.6.3 GeneOmbio Technologies Pvt Ltd. Pharmacogenomics Services Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 GeneOmbio Technologies Pvt Ltd. Main Business Overview
11.6.5 GeneOmbio Technologies Pvt Ltd. Latest Developments
11.7 Exact Sciences Corporation
11.7.1 Exact Sciences Corporation Company Information
11.7.2 Exact Sciences Corporation Pharmacogenomics Services Product Offered
11.7.3 Exact Sciences Corporation Pharmacogenomics Services Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Exact Sciences Corporation Main Business Overview
11.7.5 Exact Sciences Corporation Latest Developments
11.8 Illumina, Inc.
11.8.1 Illumina, Inc. Company Information
11.8.2 Illumina, Inc. Pharmacogenomics Services Product Offered
11.8.3 Illumina, Inc. Pharmacogenomics Services Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Illumina, Inc. Main Business Overview
11.8.5 Illumina, Inc. Latest Developments
11.9 Laboratory Corporation of America Holdings
11.9.1 Laboratory Corporation of America Holdings Company Information
11.9.2 Laboratory Corporation of America Holdings Pharmacogenomics Services Product Offered
11.9.3 Laboratory Corporation of America Holdings Pharmacogenomics Services Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Laboratory Corporation of America Holdings Main Business Overview
11.9.5 Laboratory Corporation of America Holdings Latest Developments
11.10 Myriad Genetics, Inc.
11.10.1 Myriad Genetics, Inc. Company Information
11.10.2 Myriad Genetics, Inc. Pharmacogenomics Services Product Offered
11.10.3 Myriad Genetics, Inc. Pharmacogenomics Services Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Myriad Genetics, Inc. Main Business Overview
11.10.5 Myriad Genetics, Inc. Latest Developments
11.11 OmeCare
11.11.1 OmeCare Company Information
11.11.2 OmeCare Pharmacogenomics Services Product Offered
11.11.3 OmeCare Pharmacogenomics Services Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 OmeCare Main Business Overview
11.11.5 OmeCare Latest Developments
11.12 QIAGEN N.V.
11.12.1 QIAGEN N.V. Company Information
11.12.2 QIAGEN N.V. Pharmacogenomics Services Product Offered
11.12.3 QIAGEN N.V. Pharmacogenomics Services Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 QIAGEN N.V. Main Business Overview
11.12.5 QIAGEN N.V. Latest Developments
11.13 Quest Diagnostics Incorporated
11.13.1 Quest Diagnostics Incorporated Company Information
11.13.2 Quest Diagnostics Incorporated Pharmacogenomics Services Product Offered
11.13.3 Quest Diagnostics Incorporated Pharmacogenomics Services Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Quest Diagnostics Incorporated Main Business Overview
11.13.5 Quest Diagnostics Incorporated Latest Developments
11.14 Thermo Fisher Scientific Inc.
11.14.1 Thermo Fisher Scientific Inc. Company Information
11.14.2 Thermo Fisher Scientific Inc. Pharmacogenomics Services Product Offered
11.14.3 Thermo Fisher Scientific Inc. Pharmacogenomics Services Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Thermo Fisher Scientific Inc. Main Business Overview
11.14.5 Thermo Fisher Scientific Inc. Latest Developments
11.15 Precipio
11.15.1 Precipio Company Information
11.15.2 Precipio Pharmacogenomics Services Product Offered
11.15.3 Precipio Pharmacogenomics Services Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Precipio Main Business Overview
11.15.5 Precipio Latest Developments
11.16 23andMe, Inc.
11.16.1 23andMe, Inc. Company Information
11.16.2 23andMe, Inc. Pharmacogenomics Services Product Offered
11.16.3 23andMe, Inc. Pharmacogenomics Services Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 23andMe, Inc. Main Business Overview
11.16.5 23andMe, Inc. Latest Developments
11.17 OneOme, LLC
11.17.1 OneOme, LLC Company Information
11.17.2 OneOme, LLC Pharmacogenomics Services Product Offered
11.17.3 OneOme, LLC Pharmacogenomics Services Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 OneOme, LLC Main Business Overview
11.17.5 OneOme, LLC Latest Developments
11.18 DiaCarta, Inc.
11.18.1 DiaCarta, Inc. Company Information
11.18.2 DiaCarta, Inc. Pharmacogenomics Services Product Offered
11.18.3 DiaCarta, Inc. Pharmacogenomics Services Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 DiaCarta, Inc. Main Business Overview
11.18.5 DiaCarta, Inc. Latest Developments
11.19 OPKO Health
11.19.1 OPKO Health Company Information
11.19.2 OPKO Health Pharmacogenomics Services Product Offered
11.19.3 OPKO Health Pharmacogenomics Services Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 OPKO Health Main Business Overview
11.19.5 OPKO Health Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pharmacogenomics Services Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Genotyping
Table 3. Major Players of SNP Identification
Table 4. Major Players of Pharmacogenetic Testing
Table 5. Major Players of Others
Table 6. Pharmacogenomics Services Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Pharmacogenomics Services Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Pharmacogenomics Services Market Size Market Share by Type (2019-2024)
Table 9. Pharmacogenomics Services Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Pharmacogenomics Services Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Pharmacogenomics Services Market Size Market Share by Application (2019-2024)
Table 12. Global Pharmacogenomics Services Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Pharmacogenomics Services Revenue Market Share by Player (2019-2024)
Table 14. Pharmacogenomics Services Key Players Head office and Products Offered
Table 15. Pharmacogenomics Services Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Pharmacogenomics Services Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Pharmacogenomics Services Market Size Market Share by Regions (2019-2024)
Table 20. Global Pharmacogenomics Services Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Pharmacogenomics Services Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Pharmacogenomics Services Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Pharmacogenomics Services Market Size Market Share by Country (2019-2024)
Table 24. Americas Pharmacogenomics Services Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Pharmacogenomics Services Market Size Market Share by Type (2019-2024)
Table 26. Americas Pharmacogenomics Services Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Pharmacogenomics Services Market Size Market Share by Application (2019-2024)
Table 28. APAC Pharmacogenomics Services Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Pharmacogenomics Services Market Size Market Share by Region (2019-2024)
Table 30. APAC Pharmacogenomics Services Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Pharmacogenomics Services Market Size Market Share by Type (2019-2024)
Table 32. APAC Pharmacogenomics Services Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Pharmacogenomics Services Market Size Market Share by Application (2019-2024)
Table 34. Europe Pharmacogenomics Services Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Pharmacogenomics Services Market Size Market Share by Country (2019-2024)
Table 36. Europe Pharmacogenomics Services Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Pharmacogenomics Services Market Size Market Share by Type (2019-2024)
Table 38. Europe Pharmacogenomics Services Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Pharmacogenomics Services Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Pharmacogenomics Services Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Pharmacogenomics Services Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Pharmacogenomics Services Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Pharmacogenomics Services Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Pharmacogenomics Services Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Pharmacogenomics Services Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Pharmacogenomics Services
Table 47. Key Market Challenges & Risks of Pharmacogenomics Services
Table 48. Key Industry Trends of Pharmacogenomics Services
Table 49. Global Pharmacogenomics Services Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Pharmacogenomics Services Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Pharmacogenomics Services Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Pharmacogenomics Services Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Abbott Laboratories Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
Table 54. Abbott Laboratories Pharmacogenomics Services Product Offered
Table 55. Abbott Laboratories Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Abbott Laboratories Main Business
Table 57. Abbott Laboratories Latest Developments
Table 58. Admera Health, LLC Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
Table 59. Admera Health, LLC Pharmacogenomics Services Product Offered
Table 60. Admera Health, LLC Main Business
Table 61. Admera Health, LLC Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Admera Health, LLC Latest Developments
Table 63. Mesa Laboratories, Inc. Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
Table 64. Mesa Laboratories, Inc. Pharmacogenomics Services Product Offered
Table 65. Mesa Laboratories, Inc. Main Business
Table 66. Mesa Laboratories, Inc. Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Mesa Laboratories, Inc. Latest Developments
Table 68. Dynamic DNA Laboratories Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
Table 69. Dynamic DNA Laboratories Pharmacogenomics Services Product Offered
Table 70. Dynamic DNA Laboratories Main Business
Table 71. Dynamic DNA Laboratories Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Dynamic DNA Laboratories Latest Developments
Table 73. F. Hoffmann-La Roche Ltd. Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
Table 74. F. Hoffmann-La Roche Ltd. Pharmacogenomics Services Product Offered
Table 75. F. Hoffmann-La Roche Ltd. Main Business
Table 76. F. Hoffmann-La Roche Ltd. Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. F. Hoffmann-La Roche Ltd. Latest Developments
Table 78. GeneOmbio Technologies Pvt Ltd. Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
Table 79. GeneOmbio Technologies Pvt Ltd. Pharmacogenomics Services Product Offered
Table 80. GeneOmbio Technologies Pvt Ltd. Main Business
Table 81. GeneOmbio Technologies Pvt Ltd. Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. GeneOmbio Technologies Pvt Ltd. Latest Developments
Table 83. Exact Sciences Corporation Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
Table 84. Exact Sciences Corporation Pharmacogenomics Services Product Offered
Table 85. Exact Sciences Corporation Main Business
Table 86. Exact Sciences Corporation Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Exact Sciences Corporation Latest Developments
Table 88. Illumina, Inc. Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
Table 89. Illumina, Inc. Pharmacogenomics Services Product Offered
Table 90. Illumina, Inc. Main Business
Table 91. Illumina, Inc. Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Illumina, Inc. Latest Developments
Table 93. Laboratory Corporation of America Holdings Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
Table 94. Laboratory Corporation of America Holdings Pharmacogenomics Services Product Offered
Table 95. Laboratory Corporation of America Holdings Main Business
Table 96. Laboratory Corporation of America Holdings Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Laboratory Corporation of America Holdings Latest Developments
Table 98. Myriad Genetics, Inc. Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
Table 99. Myriad Genetics, Inc. Pharmacogenomics Services Product Offered
Table 100. Myriad Genetics, Inc. Main Business
Table 101. Myriad Genetics, Inc. Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Myriad Genetics, Inc. Latest Developments
Table 103. OmeCare Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
Table 104. OmeCare Pharmacogenomics Services Product Offered
Table 105. OmeCare Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. OmeCare Main Business
Table 107. OmeCare Latest Developments
Table 108. QIAGEN N.V. Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
Table 109. QIAGEN N.V. Pharmacogenomics Services Product Offered
Table 110. QIAGEN N.V. Main Business
Table 111. QIAGEN N.V. Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 112. QIAGEN N.V. Latest Developments
Table 113. Quest Diagnostics Incorporated Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
Table 114. Quest Diagnostics Incorporated Pharmacogenomics Services Product Offered
Table 115. Quest Diagnostics Incorporated Main Business
Table 116. Quest Diagnostics Incorporated Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 117. Quest Diagnostics Incorporated Latest Developments
Table 118. Thermo Fisher Scientific Inc. Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
Table 119. Thermo Fisher Scientific Inc. Pharmacogenomics Services Product Offered
Table 120. Thermo Fisher Scientific Inc. Main Business
Table 121. Thermo Fisher Scientific Inc. Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 122. Thermo Fisher Scientific Inc. Latest Developments
Table 123. Precipio Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
Table 124. Precipio Pharmacogenomics Services Product Offered
Table 125. Precipio Main Business
Table 126. Precipio Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 127. Precipio Latest Developments
Table 128. 23andMe, Inc. Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
Table 129. 23andMe, Inc. Pharmacogenomics Services Product Offered
Table 130. 23andMe, Inc. Main Business
Table 131. 23andMe, Inc. Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 132. 23andMe, Inc. Latest Developments
Table 133. OneOme, LLC Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
Table 134. OneOme, LLC Pharmacogenomics Services Product Offered
Table 135. OneOme, LLC Main Business
Table 136. OneOme, LLC Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 137. OneOme, LLC Latest Developments
Table 138. DiaCarta, Inc. Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
Table 139. DiaCarta, Inc. Pharmacogenomics Services Product Offered
Table 140. DiaCarta, Inc. Main Business
Table 141. DiaCarta, Inc. Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 142. DiaCarta, Inc. Latest Developments
Table 143. OPKO Health Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
Table 144. OPKO Health Pharmacogenomics Services Product Offered
Table 145. OPKO Health Main Business
Table 146. OPKO Health Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 147. OPKO Health Latest Developments
Table 1. Pharmacogenomics Services Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Genotyping
Table 3. Major Players of SNP Identification
Table 4. Major Players of Pharmacogenetic Testing
Table 5. Major Players of Others
Table 6. Pharmacogenomics Services Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Pharmacogenomics Services Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Pharmacogenomics Services Market Size Market Share by Type (2019-2024)
Table 9. Pharmacogenomics Services Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Pharmacogenomics Services Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Pharmacogenomics Services Market Size Market Share by Application (2019-2024)
Table 12. Global Pharmacogenomics Services Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Pharmacogenomics Services Revenue Market Share by Player (2019-2024)
Table 14. Pharmacogenomics Services Key Players Head office and Products Offered
Table 15. Pharmacogenomics Services Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Pharmacogenomics Services Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Pharmacogenomics Services Market Size Market Share by Regions (2019-2024)
Table 20. Global Pharmacogenomics Services Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Pharmacogenomics Services Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Pharmacogenomics Services Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Pharmacogenomics Services Market Size Market Share by Country (2019-2024)
Table 24. Americas Pharmacogenomics Services Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Pharmacogenomics Services Market Size Market Share by Type (2019-2024)
Table 26. Americas Pharmacogenomics Services Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Pharmacogenomics Services Market Size Market Share by Application (2019-2024)
Table 28. APAC Pharmacogenomics Services Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Pharmacogenomics Services Market Size Market Share by Region (2019-2024)
Table 30. APAC Pharmacogenomics Services Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Pharmacogenomics Services Market Size Market Share by Type (2019-2024)
Table 32. APAC Pharmacogenomics Services Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Pharmacogenomics Services Market Size Market Share by Application (2019-2024)
Table 34. Europe Pharmacogenomics Services Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Pharmacogenomics Services Market Size Market Share by Country (2019-2024)
Table 36. Europe Pharmacogenomics Services Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Pharmacogenomics Services Market Size Market Share by Type (2019-2024)
Table 38. Europe Pharmacogenomics Services Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Pharmacogenomics Services Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Pharmacogenomics Services Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Pharmacogenomics Services Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Pharmacogenomics Services Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Pharmacogenomics Services Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Pharmacogenomics Services Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Pharmacogenomics Services Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Pharmacogenomics Services
Table 47. Key Market Challenges & Risks of Pharmacogenomics Services
Table 48. Key Industry Trends of Pharmacogenomics Services
Table 49. Global Pharmacogenomics Services Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Pharmacogenomics Services Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Pharmacogenomics Services Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Pharmacogenomics Services Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Abbott Laboratories Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
Table 54. Abbott Laboratories Pharmacogenomics Services Product Offered
Table 55. Abbott Laboratories Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Abbott Laboratories Main Business
Table 57. Abbott Laboratories Latest Developments
Table 58. Admera Health, LLC Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
Table 59. Admera Health, LLC Pharmacogenomics Services Product Offered
Table 60. Admera Health, LLC Main Business
Table 61. Admera Health, LLC Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Admera Health, LLC Latest Developments
Table 63. Mesa Laboratories, Inc. Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
Table 64. Mesa Laboratories, Inc. Pharmacogenomics Services Product Offered
Table 65. Mesa Laboratories, Inc. Main Business
Table 66. Mesa Laboratories, Inc. Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Mesa Laboratories, Inc. Latest Developments
Table 68. Dynamic DNA Laboratories Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
Table 69. Dynamic DNA Laboratories Pharmacogenomics Services Product Offered
Table 70. Dynamic DNA Laboratories Main Business
Table 71. Dynamic DNA Laboratories Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Dynamic DNA Laboratories Latest Developments
Table 73. F. Hoffmann-La Roche Ltd. Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
Table 74. F. Hoffmann-La Roche Ltd. Pharmacogenomics Services Product Offered
Table 75. F. Hoffmann-La Roche Ltd. Main Business
Table 76. F. Hoffmann-La Roche Ltd. Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. F. Hoffmann-La Roche Ltd. Latest Developments
Table 78. GeneOmbio Technologies Pvt Ltd. Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
Table 79. GeneOmbio Technologies Pvt Ltd. Pharmacogenomics Services Product Offered
Table 80. GeneOmbio Technologies Pvt Ltd. Main Business
Table 81. GeneOmbio Technologies Pvt Ltd. Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. GeneOmbio Technologies Pvt Ltd. Latest Developments
Table 83. Exact Sciences Corporation Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
Table 84. Exact Sciences Corporation Pharmacogenomics Services Product Offered
Table 85. Exact Sciences Corporation Main Business
Table 86. Exact Sciences Corporation Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Exact Sciences Corporation Latest Developments
Table 88. Illumina, Inc. Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
Table 89. Illumina, Inc. Pharmacogenomics Services Product Offered
Table 90. Illumina, Inc. Main Business
Table 91. Illumina, Inc. Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Illumina, Inc. Latest Developments
Table 93. Laboratory Corporation of America Holdings Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
Table 94. Laboratory Corporation of America Holdings Pharmacogenomics Services Product Offered
Table 95. Laboratory Corporation of America Holdings Main Business
Table 96. Laboratory Corporation of America Holdings Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Laboratory Corporation of America Holdings Latest Developments
Table 98. Myriad Genetics, Inc. Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
Table 99. Myriad Genetics, Inc. Pharmacogenomics Services Product Offered
Table 100. Myriad Genetics, Inc. Main Business
Table 101. Myriad Genetics, Inc. Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Myriad Genetics, Inc. Latest Developments
Table 103. OmeCare Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
Table 104. OmeCare Pharmacogenomics Services Product Offered
Table 105. OmeCare Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. OmeCare Main Business
Table 107. OmeCare Latest Developments
Table 108. QIAGEN N.V. Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
Table 109. QIAGEN N.V. Pharmacogenomics Services Product Offered
Table 110. QIAGEN N.V. Main Business
Table 111. QIAGEN N.V. Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 112. QIAGEN N.V. Latest Developments
Table 113. Quest Diagnostics Incorporated Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
Table 114. Quest Diagnostics Incorporated Pharmacogenomics Services Product Offered
Table 115. Quest Diagnostics Incorporated Main Business
Table 116. Quest Diagnostics Incorporated Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 117. Quest Diagnostics Incorporated Latest Developments
Table 118. Thermo Fisher Scientific Inc. Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
Table 119. Thermo Fisher Scientific Inc. Pharmacogenomics Services Product Offered
Table 120. Thermo Fisher Scientific Inc. Main Business
Table 121. Thermo Fisher Scientific Inc. Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 122. Thermo Fisher Scientific Inc. Latest Developments
Table 123. Precipio Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
Table 124. Precipio Pharmacogenomics Services Product Offered
Table 125. Precipio Main Business
Table 126. Precipio Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 127. Precipio Latest Developments
Table 128. 23andMe, Inc. Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
Table 129. 23andMe, Inc. Pharmacogenomics Services Product Offered
Table 130. 23andMe, Inc. Main Business
Table 131. 23andMe, Inc. Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 132. 23andMe, Inc. Latest Developments
Table 133. OneOme, LLC Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
Table 134. OneOme, LLC Pharmacogenomics Services Product Offered
Table 135. OneOme, LLC Main Business
Table 136. OneOme, LLC Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 137. OneOme, LLC Latest Developments
Table 138. DiaCarta, Inc. Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
Table 139. DiaCarta, Inc. Pharmacogenomics Services Product Offered
Table 140. DiaCarta, Inc. Main Business
Table 141. DiaCarta, Inc. Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 142. DiaCarta, Inc. Latest Developments
Table 143. OPKO Health Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
Table 144. OPKO Health Pharmacogenomics Services Product Offered
Table 145. OPKO Health Main Business
Table 146. OPKO Health Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 147. OPKO Health Latest Developments
LIST OF FIGURES
Figure 1. Pharmacogenomics Services Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Pharmacogenomics Services Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Pharmacogenomics Services Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Pharmacogenomics Services Sales Market Share by Country/Region (2023)
Figure 8. Pharmacogenomics Services Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Pharmacogenomics Services Market Size Market Share by Type in 2023
Figure 10. Pharmacogenomics Services in Oncology
Figure 11. Global Pharmacogenomics Services Market: Oncology (2019-2024) & ($ Millions)
Figure 12. Pharmacogenomics Services in Infectious Diseases
Figure 13. Global Pharmacogenomics Services Market: Infectious Diseases (2019-2024) & ($ Millions)
Figure 14. Pharmacogenomics Services in Psychiatry
Figure 15. Global Pharmacogenomics Services Market: Psychiatry (2019-2024) & ($ Millions)
Figure 16. Pharmacogenomics Services in Cardiovascular
Figure 17. Global Pharmacogenomics Services Market: Cardiovascular (2019-2024) & ($ Millions)
Figure 18. Pharmacogenomics Services in Others
Figure 19. Global Pharmacogenomics Services Market: Others (2019-2024) & ($ Millions)
Figure 20. Global Pharmacogenomics Services Market Size Market Share by Application in 2023
Figure 21. Global Pharmacogenomics Services Revenue Market Share by Player in 2023
Figure 22. Global Pharmacogenomics Services Market Size Market Share by Regions (2019-2024)
Figure 23. Americas Pharmacogenomics Services Market Size 2019-2024 ($ Millions)
Figure 24. APAC Pharmacogenomics Services Market Size 2019-2024 ($ Millions)
Figure 25. Europe Pharmacogenomics Services Market Size 2019-2024 ($ Millions)
Figure 26. Middle East & Africa Pharmacogenomics Services Market Size 2019-2024 ($ Millions)
Figure 27. Americas Pharmacogenomics Services Value Market Share by Country in 2023
Figure 28. United States Pharmacogenomics Services Market Size Growth 2019-2024 ($ Millions)
Figure 29. Canada Pharmacogenomics Services Market Size Growth 2019-2024 ($ Millions)
Figure 30. Mexico Pharmacogenomics Services Market Size Growth 2019-2024 ($ Millions)
Figure 31. Brazil Pharmacogenomics Services Market Size Growth 2019-2024 ($ Millions)
Figure 32. APAC Pharmacogenomics Services Market Size Market Share by Region in 2023
Figure 33. APAC Pharmacogenomics Services Market Size Market Share by Type in 2023
Figure 34. APAC Pharmacogenomics Services Market Size Market Share by Application in 2023
Figure 35. China Pharmacogenomics Services Market Size Growth 2019-2024 ($ Millions)
Figure 36. Japan Pharmacogenomics Services Market Size Growth 2019-2024 ($ Millions)
Figure 37. Korea Pharmacogenomics Services Market Size Growth 2019-2024 ($ Millions)
Figure 38. Southeast Asia Pharmacogenomics Services Market Size Growth 2019-2024 ($ Millions)
Figure 39. India Pharmacogenomics Services Market Size Growth 2019-2024 ($ Millions)
Figure 40. Australia Pharmacogenomics Services Market Size Growth 2019-2024 ($ Millions)
Figure 41. Europe Pharmacogenomics Services Market Size Market Share by Country in 2023
Figure 42. Europe Pharmacogenomics Services Market Size Market Share by Type (2019-2024)
Figure 43. Europe Pharmacogenomics Services Market Size Market Share by Application (2019-2024)
Figure 44. Germany Pharmacogenomics Services Market Size Growth 2019-2024 ($ Millions)
Figure 45. France Pharmacogenomics Services Market Size Growth 2019-2024 ($ Millions)
Figure 46. UK Pharmacogenomics Services Market Size Growth 2019-2024 ($ Millions)
Figure 47. Italy Pharmacogenomics Services Market Size Growth 2019-2024 ($ Millions)
Figure 48. Russia Pharmacogenomics Services Market Size Growth 2019-2024 ($ Millions)
Figure 49. Middle East & Africa Pharmacogenomics Services Market Size Market Share by Region (2019-2024)
Figure 50. Middle East & Africa Pharmacogenomics Services Market Size Market Share by Type (2019-2024)
Figure 51. Middle East & Africa Pharmacogenomics Services Market Size Market Share by Application (2019-2024)
Figure 52. Egypt Pharmacogenomics Services Market Size Growth 2019-2024 ($ Millions)
Figure 53. South Africa Pharmacogenomics Services Market Size Growth 2019-2024 ($ Millions)
Figure 54. Israel Pharmacogenomics Services Market Size Growth 2019-2024 ($ Millions)
Figure 55. Turkey Pharmacogenomics Services Market Size Growth 2019-2024 ($ Millions)
Figure 56. GCC Country Pharmacogenomics Services Market Size Growth 2019-2024 ($ Millions)
Figure 57. Americas Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 58. APAC Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 59. Europe Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 60. Middle East & Africa Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 61. United States Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 62. Canada Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 63. Mexico Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 64. Brazil Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 65. China Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 66. Japan Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 67. Korea Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 68. Southeast Asia Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 69. India Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 70. Australia Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 71. Germany Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 72. France Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 73. UK Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 74. Italy Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 75. Russia Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 76. Spain Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 77. Egypt Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 78. South Africa Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 79. Israel Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 80. Turkey Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 81. GCC Countries Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 82. Global Pharmacogenomics Services Market Size Market Share Forecast by Type (2025-2030)
Figure 83. Global Pharmacogenomics Services Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Pharmacogenomics Services Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Pharmacogenomics Services Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Pharmacogenomics Services Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Pharmacogenomics Services Sales Market Share by Country/Region (2023)
Figure 8. Pharmacogenomics Services Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Pharmacogenomics Services Market Size Market Share by Type in 2023
Figure 10. Pharmacogenomics Services in Oncology
Figure 11. Global Pharmacogenomics Services Market: Oncology (2019-2024) & ($ Millions)
Figure 12. Pharmacogenomics Services in Infectious Diseases
Figure 13. Global Pharmacogenomics Services Market: Infectious Diseases (2019-2024) & ($ Millions)
Figure 14. Pharmacogenomics Services in Psychiatry
Figure 15. Global Pharmacogenomics Services Market: Psychiatry (2019-2024) & ($ Millions)
Figure 16. Pharmacogenomics Services in Cardiovascular
Figure 17. Global Pharmacogenomics Services Market: Cardiovascular (2019-2024) & ($ Millions)
Figure 18. Pharmacogenomics Services in Others
Figure 19. Global Pharmacogenomics Services Market: Others (2019-2024) & ($ Millions)
Figure 20. Global Pharmacogenomics Services Market Size Market Share by Application in 2023
Figure 21. Global Pharmacogenomics Services Revenue Market Share by Player in 2023
Figure 22. Global Pharmacogenomics Services Market Size Market Share by Regions (2019-2024)
Figure 23. Americas Pharmacogenomics Services Market Size 2019-2024 ($ Millions)
Figure 24. APAC Pharmacogenomics Services Market Size 2019-2024 ($ Millions)
Figure 25. Europe Pharmacogenomics Services Market Size 2019-2024 ($ Millions)
Figure 26. Middle East & Africa Pharmacogenomics Services Market Size 2019-2024 ($ Millions)
Figure 27. Americas Pharmacogenomics Services Value Market Share by Country in 2023
Figure 28. United States Pharmacogenomics Services Market Size Growth 2019-2024 ($ Millions)
Figure 29. Canada Pharmacogenomics Services Market Size Growth 2019-2024 ($ Millions)
Figure 30. Mexico Pharmacogenomics Services Market Size Growth 2019-2024 ($ Millions)
Figure 31. Brazil Pharmacogenomics Services Market Size Growth 2019-2024 ($ Millions)
Figure 32. APAC Pharmacogenomics Services Market Size Market Share by Region in 2023
Figure 33. APAC Pharmacogenomics Services Market Size Market Share by Type in 2023
Figure 34. APAC Pharmacogenomics Services Market Size Market Share by Application in 2023
Figure 35. China Pharmacogenomics Services Market Size Growth 2019-2024 ($ Millions)
Figure 36. Japan Pharmacogenomics Services Market Size Growth 2019-2024 ($ Millions)
Figure 37. Korea Pharmacogenomics Services Market Size Growth 2019-2024 ($ Millions)
Figure 38. Southeast Asia Pharmacogenomics Services Market Size Growth 2019-2024 ($ Millions)
Figure 39. India Pharmacogenomics Services Market Size Growth 2019-2024 ($ Millions)
Figure 40. Australia Pharmacogenomics Services Market Size Growth 2019-2024 ($ Millions)
Figure 41. Europe Pharmacogenomics Services Market Size Market Share by Country in 2023
Figure 42. Europe Pharmacogenomics Services Market Size Market Share by Type (2019-2024)
Figure 43. Europe Pharmacogenomics Services Market Size Market Share by Application (2019-2024)
Figure 44. Germany Pharmacogenomics Services Market Size Growth 2019-2024 ($ Millions)
Figure 45. France Pharmacogenomics Services Market Size Growth 2019-2024 ($ Millions)
Figure 46. UK Pharmacogenomics Services Market Size Growth 2019-2024 ($ Millions)
Figure 47. Italy Pharmacogenomics Services Market Size Growth 2019-2024 ($ Millions)
Figure 48. Russia Pharmacogenomics Services Market Size Growth 2019-2024 ($ Millions)
Figure 49. Middle East & Africa Pharmacogenomics Services Market Size Market Share by Region (2019-2024)
Figure 50. Middle East & Africa Pharmacogenomics Services Market Size Market Share by Type (2019-2024)
Figure 51. Middle East & Africa Pharmacogenomics Services Market Size Market Share by Application (2019-2024)
Figure 52. Egypt Pharmacogenomics Services Market Size Growth 2019-2024 ($ Millions)
Figure 53. South Africa Pharmacogenomics Services Market Size Growth 2019-2024 ($ Millions)
Figure 54. Israel Pharmacogenomics Services Market Size Growth 2019-2024 ($ Millions)
Figure 55. Turkey Pharmacogenomics Services Market Size Growth 2019-2024 ($ Millions)
Figure 56. GCC Country Pharmacogenomics Services Market Size Growth 2019-2024 ($ Millions)
Figure 57. Americas Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 58. APAC Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 59. Europe Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 60. Middle East & Africa Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 61. United States Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 62. Canada Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 63. Mexico Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 64. Brazil Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 65. China Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 66. Japan Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 67. Korea Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 68. Southeast Asia Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 69. India Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 70. Australia Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 71. Germany Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 72. France Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 73. UK Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 74. Italy Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 75. Russia Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 76. Spain Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 77. Egypt Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 78. South Africa Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 79. Israel Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 80. Turkey Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 81. GCC Countries Pharmacogenomics Services Market Size 2025-2030 ($ Millions)
Figure 82. Global Pharmacogenomics Services Market Size Market Share Forecast by Type (2025-2030)
Figure 83. Global Pharmacogenomics Services Market Size Market Share Forecast by Application (2025-2030)
